trending Market Intelligence /marketintelligence/en/news-insights/trending/puz7hkz3zaef4uhpdexnmw2 content esgSubNav
In This List

Xtant Medical regains compliance with NYSE American exchange listing rules

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Xtant Medical regains compliance with NYSE American exchange listing rules

Xtant Medical Holdings Inc. said it resolved a previous issue with stockholders' equity deficiency and regained compliance with NYSE American exchange's continuing listing standards.

The Belgrade, Mont.-based regenerative medicine developer reported a positive stockholders' equity of approximately $47.4 million as of Feb. 15, 2018.

This reflects a restructuring agreement involving an exchange of about $70.2 million worth of debt for shares in the company with ROS Acquisition Offshore LP and OrbiMed Royalty Opportunities II LP.

The company had also exchanged debt in the principal amount of $1.6 million for 2,275,745 of its common shares and sold another 945,819 common shares in a private placement.